D.U. institutes faculty award
Stephanie Takach
Issue date: 1/16/09 Section: News
Drexel University instituted a nationwide $100,000 Anthony J. Drexel Exceptional Achievement Award for faculty, funded by an anonymous alumnus.
"The significance deals with the fact that we have been a real leader in translational research," John DiNardo, vice provost of Academic Affairs, said.
DiNardo said the award relates to Drexel's strategic plan and bringing new research from the beginning stages to the marketing stages.
"[The] strategic plan talks a lot about the idea of discovery and then translation; a lot of research has applications," DiNardo said.
Some of the applications, according to DiNardo, could be incorporated into the University's plan.
"At Drexel it's our mission to advance basic and translational research cross disciplines," Constantine Papadakis, president of Drexel University, said in a news release. "Acknowledging that our contributions to society are supported by the broader intellectual community of researchers, we created the award to recognize individuals whose work transforms both research and the society it serves."
This year, the committee is looking for dramatic new discoveries that have been brought to the stage which already have, or are on the verge of impacting medical technology.
"[The] idea of translational research is one in which fundamental research is moved to possibly the clinical setting in terms of therapeutic research, strategies for diagnosis, or possibly procedures that might heal," DiNardo said.
DiNardo added the importance of these projects for the University as a whole.
"It's an exciting opportunity for Drexel to really project itself in the community of researchers and to acknowledge the connection of other research institutions and other researchers and align our goal with some dramatic discoveries and dramatic research that have really come to fruition that has come to address medical needs amongst researchers," DiNardo said.
Once nominated through a web forum, the committee will evaluate the researchers and look to understand their work. The evaluation committee will consist of some researchers at Drexel, faculty members at Drexel and outside people, according to DiNardo.
As convener for the committee, DiNardo will coordinate all of the efforts of the committee and advance the process along until a person is chosen, as well as implement their arrival and planning. The committee is chaired by Richard E. Caruso, founder and board of directors chairman of the New Jersey based Integra Life Sciences.
"[Drexel] will put our place in the world and align ourselves with individuals who have really made a difference in the world of biomedicine," he said.
The award will be announced on May 1, 2009. The University will accept nominations from Jan. 15 through March 15.
"The significance deals with the fact that we have been a real leader in translational research," John DiNardo, vice provost of Academic Affairs, said.
DiNardo said the award relates to Drexel's strategic plan and bringing new research from the beginning stages to the marketing stages.
"[The] strategic plan talks a lot about the idea of discovery and then translation; a lot of research has applications," DiNardo said.
Some of the applications, according to DiNardo, could be incorporated into the University's plan.
"At Drexel it's our mission to advance basic and translational research cross disciplines," Constantine Papadakis, president of Drexel University, said in a news release. "Acknowledging that our contributions to society are supported by the broader intellectual community of researchers, we created the award to recognize individuals whose work transforms both research and the society it serves."
This year, the committee is looking for dramatic new discoveries that have been brought to the stage which already have, or are on the verge of impacting medical technology.
"[The] idea of translational research is one in which fundamental research is moved to possibly the clinical setting in terms of therapeutic research, strategies for diagnosis, or possibly procedures that might heal," DiNardo said.
DiNardo added the importance of these projects for the University as a whole.
"It's an exciting opportunity for Drexel to really project itself in the community of researchers and to acknowledge the connection of other research institutions and other researchers and align our goal with some dramatic discoveries and dramatic research that have really come to fruition that has come to address medical needs amongst researchers," DiNardo said.
Once nominated through a web forum, the committee will evaluate the researchers and look to understand their work. The evaluation committee will consist of some researchers at Drexel, faculty members at Drexel and outside people, according to DiNardo.
As convener for the committee, DiNardo will coordinate all of the efforts of the committee and advance the process along until a person is chosen, as well as implement their arrival and planning. The committee is chaired by Richard E. Caruso, founder and board of directors chairman of the New Jersey based Integra Life Sciences.
"[Drexel] will put our place in the world and align ourselves with individuals who have really made a difference in the world of biomedicine," he said.
The award will be announced on May 1, 2009. The University will accept nominations from Jan. 15 through March 15.
Be the first to comment on this story